TTrialPathMatch Me to Trials
← Back to trials
RecruitingEnd Stage Liver DIseaseSarcopeniaSarcopenic Obesity

Adverse Outcomes and Mortality in Liver Transplant

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.

Sponsor: Mayo Clinic

You may qualify if…

  • ✓ 1. All patients with end-stage liver disease undergoing evaluation for liver transplantation
  • ✓ 2. Patient clinically indicated for MRI during transplant candidacy evaluation
  • ✓ 3. Adult

You may not qualify if…

  • ✕ 1\. Contra indication to MRI

Where it's recruiting

Arizona

Phoenix

Source: ClinicalTrials.gov · NCT05477277 · last updated 2026-08-05

Adverse Outcomes and Mortality in Liver Transplant · TrialPath